Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Albert, Murtha"'
Autor:
MICHAEL H. WANG, WILSON ROA, KEITH WACHOWICZ, ATIYAH YAHYA, ALBERT MURTHA, JOHN AMANIE, JONATHAN CHAINEY, HARVEY QUON, SUNITA GHOSH, SAMIR PATEL
Publikováno v:
Anticancer Research. 42:2665-2673
The purpose of this study was to evaluate the association of specific threshold values for changes in metabolic metrics measured from 1H magnetic resonance spectroscopic imaging (MRSI) to survival of patients with high-grade glioma treated with multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c00da11a7ce82fca2cd8784eb8a7512
https://doi.org/10.21873/anticanres.15744
https://doi.org/10.21873/anticanres.15744
Publikováno v:
Ambiente & Sociedade, Vol 18, Iss 3, Pp 193-210 (2015)
ResumoO artigo objetiva oferecer uma visão histórica de fatores que induziram ou influenciaram as primeiras políticas públicas de saneamento e de recursos hídricos no Brasil. Um dos pressupostos adotados é o de que o desenvolvimento socioeconô
Externí odkaz:
https://doaj.org/article/e223b3a9191942c389883a78228fe7de
Autor:
Albert Murtha, Matthew P. Larocque, Kelsey A. Roelofs, Ezekiel Weis, Parampal S. Grewal, Steven Lapere
Publikováno v:
British Journal of Ophthalmology. 106:724-730
BackgroundLargest basal diameter (LBD) appears to have independent prognostic value in uveal melanoma (UM).MethodsAll patients undergoing plaque brachytherapy or enucleation for UM involving the choroid and/or ciliary body between 2012 and 2019.Resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f424cbb92c648d617c639883bfdec5
https://doi.org/10.1136/bjophthalmol-2020-317714
https://doi.org/10.1136/bjophthalmol-2020-317714
Autor:
Fan Yang, Deepak Dinakaran, Amr A. Heikal, Shima Yaghoobpour Tari, Sunita Ghosh, John Amanie, Albert Murtha, Lindsay S. Rowe, Wilson H. Roa, Samir Patel
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 177
There is no consensus on appropriate organ at risk (OAR) constraints for short-course radiotherapy for patients with glioblastoma. Using dosimetry and prospectively-collected toxicity data from a trial of short-course radiotherapy for glioblastoma, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89f037f38205b895076f7778dbc1f23
https://pubmed.ncbi.nlm.nih.gov/36273738
https://pubmed.ncbi.nlm.nih.gov/36273738
Publikováno v:
Current Cancer Therapy Reviews. 16:182-195
Radiotherapy is an important component of the treatment for primary and metastatic brain tumors. Due to the close proximity of critical structures and normal brain parenchyma, Central Nervous System (CNS) radiotherapy is associated with adverse effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88b891efcd765a4e296a33dd4e88f861
https://doi.org/10.2174/1573394715666181129105542
https://doi.org/10.2174/1573394715666181129105542
Autor:
Fan Yang, Sunita Ghosh, Don Yee, Samir Patel, Nadeem Pervez, Matthew Parliament, Nawaid Usmani, Brita Danielson, John Amanie, Robert Pearcey, Colin Field, Gino Fallone, Albert Murtha
Publikováno v:
International journal of radiation oncology, biology, physics. 114(1)
In this study, we report the 24-month patient-reported outcomes of the randomized phase 2 CHIRP trial that compared conventional and hypofractionated radiation therapy (RT) in the treatment of high-risk prostate cancer.Men with high-risk localized pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e913eff3f6b9a895e1c8ead6290e9f8
https://pubmed.ncbi.nlm.nih.gov/35843786
https://pubmed.ncbi.nlm.nih.gov/35843786
Autor:
Gerard Morton, Edouard J. Trabulsi, Albert Murtha, Juanita Crook, David C. Beyer, Thomas M. Pisansky, Howard Sandler, Mahul B. Amin, Eric M. Horwitz, Ashesh B. Jani, Eric Vigneault, Adam Raben, J. Rodgers, Mack Roach, Jeff M. Michalski, William S. Bice, Stephanie L. Pugh, Joelle Helou
Publikováno v:
International journal of radiation oncology, biology, physics, vol 112, iss 5
PurposeWe report efficacy of a prospective phase 2 trial (NCT00450411) of salvage low-dose-rate (LDR) prostate brachytherapy (BT) for local failure (LF) after prior external beam radiation therapy (EBRT) with minimum 5-years' follow-up.Methods and ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::545e93ed949d644beef31043296d73e0
https://pubmed.ncbi.nlm.nih.gov/35286882
https://pubmed.ncbi.nlm.nih.gov/35286882
Autor:
Robert Pearcey, Samir H. Patel, Don Yee, Nawaid Usmani, Brita Danielson, Matthew Parliament, G. Dundas, J. Pederson, Fan Yang, Albert Murtha, Sunita Ghosh, Colin Field, John Amanie, Gino Fallone
Publikováno v:
Radiotherapy and Oncology. 163:S16-S17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de54b9b1461bb8b4a2b723ad1ba456ad
https://doi.org/10.1016/s0167-8140(21)08910-6
https://doi.org/10.1016/s0167-8140(21)08910-6
Autor:
Michael H. Wang, Nadeem Pervez, Brita Danielson, John Amanie, Sunita Ghosh, Robert Pearcey, Don Yee, Colin Field, Samir Patel, Albert Murtha, Matthew Parliament, B. Gino Fallone, Larissa J. Vos, Nawaid Usmani
Publikováno v:
Practical radiation oncology. 11(5)
Purpose Hypofractionated radiation therapy (HFRT) may offer treatment advantages for patients with prostate cancer. However, HFRT may also increase the risk of gastrointestinal (GI) or genitourinary (GU) toxicity compared with conventionally fraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49cbad081ce94b0e98da567220cfa261
https://pubmed.ncbi.nlm.nih.gov/33705985
https://pubmed.ncbi.nlm.nih.gov/33705985
Autor:
Ziyan Liu, Minhee Won, Edward G. Shaw, Andrea L. Salavaggione, David G. Johnson, Aline Paixão Becker, Ian R. Crocker, Minesh P. Mehta, Jessica Fleming, Arnab Chakravarti, Erica Hlavin Bell, Kenneth Aldape, Cynthia Timmers, Peixin Zhang, Dennis E. Bullard, Albert Murtha, Geoffrey R. Barger, Christopher J. Schultz, David Brachman, Grant K. Hunter, Mark R. Gilbert, Nadia Laack, Stanley Z. Gertler, Keith J. Stelzer, Jan C. Buckner, Joseph P. McElroy, Paul D. Brown
Publikováno v:
J Clin Oncol
PURPOSE NRG Oncology/RTOG 9802 (ClinicalTrials.gov Identifier: NCT00003375 ) is a practice-changing study for patients with WHO low-grade glioma (LGG, grade II), as it was the first to demonstrate a survival benefit of adjuvant chemoradiotherapy over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b12ab71274bee194a6b2919dfa8f74
https://europepmc.org/articles/PMC7527157/
https://europepmc.org/articles/PMC7527157/
